Characteristics | n = 36 (%) |
---|---|
Specialty | |
Psychiatry | 6 (17) |
Cardiology | 5 (14) |
Respiratory medicine | 5 (14) |
Infectious diseases | 5 (14) |
Neurology | 2 (6) |
Rheumatology | 2 (6) |
Dermatology | 2 (6) |
Complementary-alternative medicine | 2 (6) |
Gastroenterology | 1 (3) |
Medicala | 3 (8) |
No information | 3 (8) |
Formulation types | |
Tablet | 17 (47) |
Capsule | 12 (33) |
Liquid (injection and oral medicament) | 2 (6) |
Ointment | 2 (6) |
Aerosol | 2 (6) |
Nasal spray | 1 (3) |
Type of control intervention | |
Placebo | 33 (92) |
Active | 3 (8) |
Producer of the interventions | |
Pharmaceutical company | 25 (69) |
Investigators | 1 (3) |
Not reported | 9 (25) |
Pharmacy | 1 (3) |
Method of comparison | |
Group of assessors | |
Assessors n = 4 | 26 (72) |
Assessors n = 32-52 | 8 (22) |
Pilot trial | 2 (6) |